CETUXIMAB AND BEVACIZUMAB AS FIRST-LINE THERAPY FOLLOWED BY COMBINATION CHEMOTHERAPY AND BEVACIZUMAB WITH OR WITHOUT CETUXIMAB AS SECOND-LINE THERAPY IN TREATING PATIENTS WITH STAGE IV COLORECTAL CANCER: